[eGongsi Notice] Exicon Signs Supply Contract Worth 6.1 Billion KRW with Samsung Electronics, etc. (Morning Summary)

[Asia Economy Reporter Hwang Yoon-joo] Exicon announced on the 24th that it has signed a semiconductor inspection equipment contract worth 6.1 billion KRW with Samsung Electronics. This accounts for 9.3% of recent sales, and the contract period is from October 21, 2022, to June 30, 2023.

▲ Platiere = Decided to acquire treasury shares worth 3 billion KRW to enhance shareholder value. The treasury share trust contract period is from October 25, 2022, to April 24, 2023.

▲ Konic Automation = Signed a supply contract for an inspection automation system worth 1.4 billion KRW with LG Chem. This is 5.24% of recent sales, and the contract period is from October 21, 2022, to July 31, 2023.

▲ PI Advanced Materials = Operating profit for Q3 was 14 billion KRW, down 26.5% compared to the same period last year. Sales were 70.2 billion KRW, down 12.5%, and net profit fell by 13.2%.

▲ POSCO ICT = Operating profit for Q3 was 16.9 billion KRW, turning to a profit compared to the same period last year. Sales increased by 11.9% to 239.4 billion KRW, and net profit turned positive to 14.9 billion KRW.

▲ C&G Hightech = Signed a semiconductor manufacturing equipment supply contract worth 53.4 billion KRW with Samsung Electronics. This accounts for 52.74% of recent sales, and the contract period is from October 21, 2022, to December 28, 2022.

▲ NI Steel = Operating profit for Q3 was 16 billion KRW, up 125.7% compared to the same period last year. Sales increased by 45.6% to 88.8 billion KRW, and net profit rose 123.2% to 11.1 billion KRW.

▲ SG&G = Announced the withdrawal of the decision to transfer the land parcels and buildings at 182 Gasa-dong, Anseong-si, Gyeonggi-do, contracted with YG Plus Development. Since the contract counterparty failed to pay the balance, the contract was canceled, and the deposit of 4 billion KRW was forfeited as a penalty.

▲ CTC Bio = Announced that the efficacy of the combination drug under development for premature ejaculation and erectile dysfunction (CDFR0812-15/50mg) was confirmed in Phase 3 clinical trials. This drug is a combination of the premature ejaculation treatment Mipramine (Condensia tablets) and the erectile dysfunction treatment Sildenafil (original product name Viagra tablets).